Cardiome Pharma Corporation EBITDA 2016-2019 | CORV
Cardiome Pharma Corporation ebitda from 2016 to 2019. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Cardiome Pharma Corporation Annual EBITDA (Millions of US $) |
|
|---|---|
| 2019 | $-24 |
| 2018 | $-22 |
| 2017 | $-19 |
| 2016 | $-12 |
| 2015 | $-19 |
| 2014 | $-14 |
| 2013 | $ |
| 2011 | $ |
| 2009 | $ |
| Cardiome Pharma Corporation Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2019-09-30 | $-8 |
| 2019-03-31 | $-6 |
| 2018-12-31 | $-3 |
| 2018-09-30 | $-4 |
| 2018-06-30 | $-8 |
| 2018-03-31 | $-7 |
| 2017-12-31 | $-5 |
| 2017-09-30 | $-4 |
| 2017-06-30 | $-6 |
| 2017-03-31 | $-5 |
| 2016-12-31 | $-4 |
| 2016-09-30 | $-3 |
| 2016-06-30 | $-4 |
| 2016-03-31 | $-1 |
| 2015-12-31 | $-6 |
| 2015-09-30 | $-4 |
| 2015-06-30 | $-7 |
| 2015-03-31 | $-2 |
